SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: zebraspot who wrote (564)5/4/1998 7:48:00 PM
From: Nero  Read Replies (1) of 2135
 
With you Zebra.

Yes, the fundamentals of ENMD have not changed. Yes, clinical trials haven't even begun. Yes, many ''cures'' never make it to market. But . . .

What has changed is the public's perception of ENMD's products. The NYT on Sunday made the cancer-curing mechanisms clear to the layman. What even I can understand is that the curative mechanics at work seem likely to withstand the physiological differences between mice and humans.

This isn't the latest internet search engine or even a new drug to allow erections . . . this is a lifeline for tens of millions of people. Tough to put a price on. Very difficult to say this germ of an idea tested successfully on small mammals is not worth $100 a share. No, this ain't KTEL folks.

Sure the investing risks are large, but the potential rewards are huge. Put a price on life?

I'm in at $58.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext